Traditional Chinese medicine: A promising candidate for the treatment of Alzheimer's disease

Translational Neurodegeneration

Volumn 2, Issue 1, 2013, Pages

  Sun, Zhi Kun ^a   Yang, Hong Qi ^a   Chen, Sheng Di ^b  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Alzheimer's disease; Chinese traditional medicine; Therapeutic approach

Indexed keywords

CENTELLA ASIATICA EXTRACT; CENTRAL NERVOUS SYSTEM AGENTS; CRYPTOTANSHINONE; CURCUMIN; DX 9386; GINKGO BILOBA EXTRACT; GINSENG EXTRACT PLUS EPIMEDIUM EXTRACT PLUS POLYGALA EXTRACT PLUS CURCUMAE EXTRACT; HERBACEOUS AGENT; HUPERZINE A; KAMI UTAN TO; MELISSA OFFICINALIS EXTRACT; PHYTOSTEROL; PLACEBO; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; POLYGALA TENUIFOLIA EXTRACT; SALIDROSIDE; SITOINDOSIDE DERIVATIVE; TANSHINONE; UNCLASSIFIED DRUG; VINPOCETINE; WITHAFERIN A; WITHANIA SOMNIFERA EXTRACT;

ALZHEIMER DISEASE; AMNESIA; ANKLE EDEMA; ANTIOXIDANT ACTIVITY; BEHAVIOR DISORDER; CENTELLA ASIATICA; CHINESE MEDICINE; COGNITIVE DEFECT; DRUG ABSORPTION; DRUG EFFICACY; DRUG MECHANISM; DRUG PENETRATION; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; GASTROINTESTINAL SYMPTOM; HUMAN; HYSTERIA; INSOMNIA; LEARNING DISORDER; MELANCHOLIA; MELISSA OFFICINALIS; MEMORY DISORDER; MIGRAINE; MINI MENTAL STATE EXAMINATION; NERVOUS SYSTEM INJURY; NEURITIS; NEUROPROTECTION; NEUROSIS; NIGHTMARE; NONHUMAN; PLANT LEAF; PLANT ROOT; POLYGALA TENUIFOLIA; PRIORITY JOURNAL; REVIEW; RHIZOME; SALVIA MILTIORRHIZA; WITHANIA SOMNIFERA;

EID: 84883601487     PISSN: None     EISSN: 20479158     Source Type: Journal    
DOI: 10.1186/2047-9158-2-6     Document Type: Review

References (68)

1. Ved HS, Koenig ML, Dave JR, Doctor BP. Huperzine A, a potential therapeutic agent for dementia, reduces neuronal cell death caused by glutamate. Neuroreport 1997, 8(4):963-968. 10.1097/00001756-199703030-00029, 9141073.
2. Wang R, Tang XC. Neuroprotective effects of huperzine A: a natural cholinesterase inhibitor for the treatment of Alzheimer's disease. Neurosignals 2005, 14(1-2):71-82.
3. Yang L, Ye CY, Huang XT, Tang XC, Zhang HY. Decreased accumulation of subcellular amyloid-beta with improved mitochondrial function mediates the neuroprotective effect of huperzine A. J Alzheimers Dis 2012, 31(1):131-142.
4. Wang Y, Tang XC, Zhang HY. Huperzine A alleviates synaptic deficits and modulates amyloidogenic and nonamyloidogenic pathways in APPswe/PS1dE9 transgenic mice. J Neurosci Res 2012, 90(2):508-517. 10.1002/jnr.22775, 22002568.
5. Ratia M, Gimenez-Llort L, Camps P, Munoz-Torrero D, Perez B, Clos MV, Badia A. Huprine X and huperzine a improve cognition and regulate some neurochemical processes related with Alzheimer's disease in triple transgenic mice(3xTg-AD). Neurodegener Dis 2012, Epub ahead of print.
6. Wang CY, Zheng W, Wang T, Xie JW, Wang SL, Zhao BL, Teng WP, Wang ZY. Huperzine a activates Wnt/beta-catenin signaling and enhances the nonamyloidogenic pathway in an alzheimer transgenic mouse model. Neuropsychopharmacology 2011, 36(5):1073-1089. 10.1038/npp.2010.245, 3077275, 21289607.
7. Wang BS, Wang H, Wei ZH, Song YY, Zhang L, Chen HZ. Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: an updated meta-analysis. J Neural Transm 2009, 116(4):457-465. 10.1007/s00702-009-0189-x, 19221692.
8. Rafii MS, Walsh S, Little JT, Behan K, Reynolds B, Ward C, Jin S, Thomas R, Aisen PS. A phase II trial of huperzine A in mild to moderate alzheimer disease. Neurology 2011, 76(16):1389-1394. 10.1212/WNL.0b013e318216eb7b, 3269774, 21502597.
9. Zhang Z, Wang X, Chen Q, Shu L, Wang J, Shan G. Clinical efficacy and safety of huperzine alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial. Zhonghua Yi Xue Za Zhi 2002, 82(14):941-944.
10. Topic B, Tani E, Tsiakitzis K, Kourounakis PN, Dere E, Hasenohrl RU, Hacker R, Mattern CM, Huston JP. Enhanced maze performance and reduced oxidative stress by combined extracts of zingiber officinale and ginkgo biloba in the aged rat. Neurobiol Aging 2002, 23(1):135-143. 10.1016/S0197-4580(01)00241-X, 11755028.
11. Bastianetto S, Ramassamy C, Dore S, Christen Y, Poirier J, Quirion R. The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid. Eur J Neurosci 2000, 12(6):1882-1890. 10.1046/j.1460-9568.2000.00069.x, 10886329.
12. Yao Z, Drieu K, Papadopoulos V. The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from beta-amyloid-induced cell death by inhibiting the formation of beta-amyloid-derived diffusible neurotoxic ligands. Brain Res 2001, 889(1-2):181-190.
13. Shi C, Wu F, Xu J. H2O2 and PAF mediate Abeta1-42-induced Ca2+ dyshomeostasis that is blocked by EGb761. Neurochem Int 2010, 56(18):893-905.
14. Stoll S, Scheuer K, Pohl O, Muller WE. Ginkgo biloba extract (EGb 761) independently improves changes in passive avoidance learning and brain membrane fluidity in the aging mouse. Pharmacopsychiatry 1996, 29(4):144-149.
15. Oken BS, Storzbach DM, Kaye JA. The efficacy of ginkgo biloba on cognitive function in alzheimer disease. Arch Neurol 1998, 55(11):1409-1415. 10.1001/archneur.55.11.1409, 9823823.
16. Rigney U, Kimber S, Hindmarch I. The effects of acute doses of standardized ginkgo biloba extract on memory and psychomotor performance in volunteers. Phytother Res 1999, 13(5):408-415. 10.1002/(SICI)1099-1573(199908/09)13:5<408::AID-PTR530>3.0.CO;2-C, 10441781.
17. Ihl R, Tribanek M, Bachinskaya N. Efficacy and tolerability of a once daily formulation of ginkgo biloba extract EGb 761(R) in Alzheimer's disease and vascular dementia: results from a randomised controlled trial. Pharmacopsychiatry 2012, 45(2):41-46.
18. Snitz BE, O'Meara ES, Carlson MC, Arnold AM, Ives DG, Rapp SR, Saxton J, Lopez OL, Dunn LO, Sink KM, DeKosky ST. Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA 2009, 302(24):2663-2670. 10.1001/jama.2009.1913, 2832285, 20040554.
19. Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 2005, 280(7):5892-5901.
20. Ringman JM, Frautschy SA, Cole GM, Masterman DL, Cummings JL. A potential role of the curry spice curcumin in alzheimer's disease. Curr Alzheimer Res 2005, 2(2):131-136. 10.2174/1567205053585882, 1702408, 15974909.
21. Zhang L, Fiala M, Cashman J, Sayre J, Espinosa A, Mahanian M, Zaghi J, Badmaev V, Graves MC, Bernard G, Rosenthal M. Curcuminoids enhance amyloid-beta uptake by macrophages of alzheimer's disease patients. J Alzheimers Dis 2006, 10(1):1-7.
22. Ishrat T, Hoda MN, Khan MB, Yousuf S, Ahmad M, Khan MM, Ahmad A, Islam F. Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT). Eur Neuropsychopharmacol 2009, 19(9):636-647. 10.1016/j.euroneuro.2009.02.002, 19329286.
23. Sun XK, Zhao YX, Ding JQ, Yang HQ, Qian K, Pan J, Lu GQ. Inhibitory effect of Curcumin on apoptosis of PCI2 cells induced by amyloid 25-35. ShangHai Med J 2007, 30(11):843-846.
24. Wang HM, Zhao YX, Zhang S, Liu GD, Kang WY, Tang HD, Ding JQ, Chen SD. PPARgamma agonist curcumin reduces the amyloid-beta-stimulated inflammatory responses in primary astrocytes. J Alzheimers Dis 2010, 20(4):1189-1199.
25. Qin XY, Cheng Y, Yu LC. Potential protection of curcumin against intracellular amyloid beta-induced toxicity in cultured rat prefrontal cortical neurons. Neurosci Lett 2010, 480(1):21-24. 10.1016/j.neulet.2010.05.062, 20638958.
26. Ringman JM, Frautschy SA, Teng E, Begum AN, Bardens J, Beigi M, Gylys K, Badmaev V, Heath D, Apostolova LG, Porter V, Vanek Z, Marshall GA, Hellemann G, Sugar C, Masterman D, Montine TJ, Cummings JL, Cole GM. Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimers Res Ther 2012, 4(5):43. Epub ahead of print, 10.1186/alzrt146, 3580400, 23107780.
27. Zhang L, Yu H, Zhao X, Lin X, Tan C, Cao G, Wang Z. Neuroprotective effects of salidroside against beta-amyloid-induced oxidative stress in SH-SY5Y human neuroblastoma cells. Neurochem Int 2010, 57(5):547-555. 10.1016/j.neuint.2010.06.021, 20615444.
28. Qu ZQ, Zhou Y, Zeng YS, Lin YK, Li Y, Zhong ZQ, Chan WY. Protective effects of a rhodiola crenulata extract and salidroside on hippocampal neurogenesis against streptozotocin-induced neural injury in the rat. PLoS One 2012, 7(1):e29641. 10.1371/journal.pone.0029641, 3250459, 22235318.
29. Li QY, Wang HM, Wang ZQ, Ma JF, Ding JQ, Chen SD. Salidroside attenuates hypoxia-induced abnormal processing of amyloid precursor protein by decreasing BACE1 expression in SH-SY5Y cells. Neurosci Lett 2010, 481(3):154-158. 10.1016/j.neulet.2010.06.076, 20599477.
30. Hoi CP, Ho YP, Baum L, Chow AH. Neuroprotective effect of honokiol and magnolol, compounds from magnolia officinalis, on beta-amyloid-induced toxicity in PC12 cells. Phytother Res 2010, 24(10):1538-1542. 10.1002/ptr.3178, 20878707.
31. Erdo SL, Cai NS, Wolff JR, Kiss B. Vinpocetin protects against excitotoxic cell death in primary cultures of rat cerebral cortex. Eur J Pharmacol 1990, 187(3):551-553. 10.1016/0014-2999(90)90386-K, 1981558.
32. Bonoczk P, Gulyas B, Adam-Vizi V, Nemes A, Karpati E, Kiss B, Kapas M, Szantay C, Koncz I, Zelles T, Vas A. Role of sodium channel inhibition in neuroprotection: effect of vinpocetine. Brain Res Bull 2000, 53(3):245-254. 10.1016/S0361-9230(00)00354-3, 11113577.
33. Deshmukh R, Sharma V, Mehan S, Sharma N, Bedi KL. Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine-a PDE1 inhibitor. Eur J Pharmacol 2009, 620(1-3):49-56.
34. Szatmari SZ, Whitehouse PJ. Vinpocetine for cognitive impairment and dementia. Cochrane Database Syst Rev 2003, 1:CD003119.
35. Akhondzadeh S, Abbasi SH. Herbal medicine in the treatment of Alzheimer's disease. Am J Alzheimers Dis Other Demen 2006, 21(2):113-118. 10.1177/153331750602100211, 16634467.
36. Manyam BV. Dementia in ayurveda. J Altern Complement Med 1999, 5(1):81-88. 10.1089/acm.1999.5.81, 10100034.
37. Brinkhaus B, Lindner M, Schuppan D, Hahn EG. Chemical, pharmacological and clinical profile of the East Asian medical plant centella asiatica. Phytomedicine 2000, 7(5):427-448. 10.1016/S0944-7113(00)80065-3, 11081995.
38. Nalini K, Karanth KS, Rao A, Aroor AR. Effects of piracetam on retention and biogenic amine turnover in albino rats. Pharmacol Biochem Behav 1992, 42(4):859-864. 10.1016/0091-3057(92)90041-D, 1513869.
39. Lee MK, Kim SR, Sung SH, Lim D, Kim H, Choi H, Park HK, Je S, Ki YC. Asiatic acid derivatives protect cultured cortical neurons from glutamate-induced excitotoxicity. Res Commun Mol Pathol Pharmacol 2000, 108(1-2):75-86.
40. Dhanasekaran M, Holcomb LA, Hitt AR, Tharakan B, Porter JW, Young KA, Manyam BV. Centella asiatica extract selectively decreases amyloid beta levels in hippocampus of Alzheimer's disease animal model. Phytother Res 2009, 23(1):14-19. 10.1002/ptr.2405, 19048607.
41. Veerendra Kumar MH, Gupta YK. Effect of Centella asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer's disease in rats. Clin Exp Pharmacol Physiol 2003, 30(5-6):336-342.
42. Tildesley NT, Kennedy DO, Perry EK, Ballard CG, Savelev S, Wesnes KA, Scholey AB. Salvia lavandulaefolia (Spanish sage) enhances memory in healthy young volunteers. Pharmacol Biochem Behav 2003, 75(3):669-674. 10.1016/S0091-3057(03)00122-9, 12895685.
43. Sadraei H, Ghannadi A, Malekshahi K. Relaxant effect of essential oil of melissa officinalis and citral on rat ileum contractions. Fitoterapia 2003, 74(5):445-452. 10.1016/S0367-326X(03)00109-6, 12837359.
44. Howes MJ, Perry NS, Houghton PJ. Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders. Phytother Res 2003, 17(1):1-18. 10.1002/ptr.1280, 12557240.
45. Marongiu B, Porcedda S, Piras A, Rosa A, Deiana M, Dessi MA. Antioxidant activity of supercritical extract of melissa officinalis subsp officinalis and melissa officinalis subsp inodora. Phytother Res 2004, 18(10):789-792. 10.1002/ptr.1549, 15551397.
46. Wake G, Court J, Pickering A, Lewis R, Wilkins R, Perry E. CNS acetylcholine receptor activity in European medicinal plants traditionally used to improve failing memory. J Ethnopharmacol 2000, 69(2):105-114. 10.1016/S0378-8741(99)00113-0, 10687867.
47. Iwasaki K, Satoh-Nakagawa T, Maruyama M, Monma Y, Nemoto M, Tomita N, Tanji H, Fujiwara H, Seki T, Fujii M, Arai H, Sasaki H. A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. J Clin Psychiatry 2005, 66(2):248-252. 10.4088/JCP.v66n0214, 15705012.
48. Kennedy DO, Little W, Scholey AB. Attenuation of laboratory-induced stress in humans after acute administration of melissa officinalis (lemon balm). Psychosom Med 2004, 66(4):607-613. 10.1097/01.psy.0000132877.72833.71, 15272110.
49. Kennedy DO, Wake G, Savelev S, Tildesley NT, Perry EK, Wesnes KA, Scholey AB. Modulation of mood and cognitive performance following acute administration of single doses of melissa officinalis (lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties. Neuropsychopharmacology 2003, 28(10):1871-1881. 10.1038/sj.npp.1300230, 12888775.
50. Cheng MC, Li CY, Ko HC, Ko FN, Lin YL, Wu TS. Antidepressant principles of the roots of polygala tenuifolia. J Nat Prod 2006, 69(9):1305-1309. 10.1021/np060207r, 16989524.
51. Lv J, Jia H, Jiang Y, Ruan Y, Liu Z, Yue W, Beyreuther K, Tu P, Zhang D. Tenuifolin, an extract derive d from tenuigenin, inhibits amyloid-beta secretion in vitro. Acta Physiol (Oxf) 2009, 196(4):419-425.
52. Nishiyama N, Zhou Y, Saito H. Beneficial effects of DX-9386, a traditional Chinese prescription, on memory disorder produced by lesioning the amygdala in mice. Biol Pharm Bull 1994, 17(12):1679-1681. 10.1248/bpb.17.1679, 7735219.
53. Nishiyama N, Zhou Y, Saito H. Ameliorative effects of chronic treatment using DX-9386, a traditional Chinese prescription, on learning performance and lipid peroxide content in senescence accelerated mouse. Biol Pharm Bull 1994, 17(11):1481-1484. 10.1248/bpb.17.1481, 7703968.
54. Tian J, Shi J, Zhang XK, Wang YY. Herbal therapy: a new pathway of the treatment for Alzheimer's disease. Alzheimer's Res Ther 2010, 2(5):30-33. 10.1186/alzrt54, 23463024.
55. Tian J, Shi J, Zhang L, Yin J, Hu Q, Xu Y, Sheng S, Wang P, Ren Y, Wang R, Wang Y. GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice. Curr Alzheimer Res 2009, 6(2):118-131. 10.2174/156720509787602942, 19355846.
56. Shi J, Tian J, Zhang X, Wei M, Yin L, Wang P, Wang Y. A combination extract of ginseng, epimedium, polygala, and tuber curcumae increases synaptophysin expression in APPV717I transgenic mice. Chin Med 2012, 7(1):13. 10.1186/1749-8546-7-13, 3508886, 22681961.
57. Yabe T, Tuchida H, Kiyohara H, Takeda T, Yamada H. Induction of NGF synthesis in astrocytes by onjisaponins of Polygala tenuifolia, constituents of kampo (Japanese herbal) medicine, Ninjin-yoei-to. Phytomedicine 2003, 10(2-3):106-114.
58. Kim JS, Narula AS, Jobin C. Salvia miltiorrhiza water-soluble extract, but not its constituent salvianolic acid B, abrogates LPS-induced NF-kappaB signalling in intestinal epithelial cells. Clin Exp Immunol 2005, 141(2):288-297. 10.1111/j.1365-2249.2005.02844.x, 1809446, 15996193.
59. Kuang P, Wu W, Zhu K. Evidence for amelioration of cellular damage in ischemic rat brain by radix salviae miltiorrhizae treatment-immunocytochemistry and histopathology studies. J Tradit Chin Med 1993, 13(1):38-41.
60. Loizzo MR, Tundis R, Conforti F, Menichini F, Bonesi M, Nadjafi F, Frega NG. Salvia leriifolia Benth (Lamiaceae) extract demonstrates in vitro antioxidant properties and cholinesterase inhibitory activity. Nutr Res 2010, 30(12):823-830. 10.1016/j.nutres.2010.09.016, 21147365.
61. Mei Z, Zhang F, Tao L, Zheng W, Cao Y, Wang Z, Tang S, Le K, Chen S, Pi R, Liu P. Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro. Neurosci Lett 2009, 452(2):90-95. 10.1016/j.neulet.2009.01.013, 19154776.
62. Newhouse PA, Kelton M. Nicotinic systems in central nervous systems disease: degenerative disorders and beyond. Pharm Acta Helv 2000, 74(2-3):91-101.
63. van Duijn CM, Hofman A. Relation between nicotine intake and Alzheimer's disease. BMJ 1991, 302(6791):1491-1494. 10.1136/bmj.302.6791.1491, 1670208, 1855016.
64. Matsuda H, Murakami T, Kishi A, Yoshikawa M. Structures of withanosides I, II, III, IV, V, VI, and VII, new withanolide glycosides, from the roots of Indian Withania somnifera DUNAL and inhibitory activity for tachyphylaxis to clonidine in isolated guinea-pig ileum. Bioorg Med Chem 2001, 9(6):1499-1507. 10.1016/S0968-0896(01)00024-4, 11408168.
65. Grover A, Shandilya A, Agrawal V, Bisaria VS, Sundar D. Computational evidence to inhibition of human acetyl cholinesterase by withanolide a for alzheimer treatment. J Biomol Struct Dyn 2012, 29(4):651-662. 10.1080/07391102.2012.10507408, 22208270.
66. Jayaprakasam B, Padmanabhan K, Nair MG. Withanamides in Withania somnifera fruit protect PC-12 cells from beta-amyloid responsible for Alzheimer's disease. Phytother Res 2010, 24(6):859-863.
67. Kumar S, Seal CJ, Howes MJ, Kite GC, Okello EJ. In vitro protective effects of Withania somnifera (L) dunal root extract against hydrogen peroxide and beta-amyloid(1-42)-induced cytotoxicity in differentiated PC12 cells. Phytother Res 2010, 24(10):1567-1574. 10.1002/ptr.3261, 20680931.
68. Rasool M, Varalakshmi P. Protective effect of Withania somnifera root powder in relation to lipid peroxidation, antioxidant status, glycoproteins and bone collagen on adjuvant-induced arthritis in rats. Fundam Clin Pharmacol 2007, 21(2):157-164. 10.1111/j.1472-8206.2006.00461.x, 17391288.